Angle acquiring 'certain assets' of Axela in £3.7m deal
Updated : 15:26
Liquid biopsy company Angle announced the conditional acquisition of certain assets of Axela on Thursday, for a total consideration of CAD 6.15m (£3.7m), together with a conditional placing and subscriptions to raise £12.2m at 35p per new ordinary share.